Get the Stockscreener App
2.75
4.17%
0.11
Rezolute Inc stock is traded at $2.75, with a volume of 907.04K.
It is up +4.17% in the last 24 hours and down -21.43% over the past month.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
See More
Previous Close:
$2.64
Open:
$2.64
24h Volume:
907.04K
Relative Volume:
1.55
Market Cap:
$155.58M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-2.1654
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
+11.34%
1M Performance:
-21.43%
6M Performance:
-41.98%
1Y Performance:
-15.12%
1-Day Range:
$2.63
$2.80
1-Week Range:
$2.38
$2.80
52-Week Range:
$2.215
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
2.75 | 155.58M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Rezolute, Inc. (NASDAQ:RZLT) Position Boosted by American Century Companies Inc. - Defense World
Rezolute (RZLT) Upgraded to Buy: What Does It Mean for the Stock? - NewsBreak: Local News & Alerts
RZLT stock touches 52-week low at $2.3 amid market fluctuations By Investing.com - Investing.com South Africa
RZLT stock touches 52-week low at $2.3 amid market fluctuations - Investing.com Australia
Rezolute, Inc. (NASDAQ:RZLT) CEO Nevan C. Elam Purchases 12,302 Shares - MarketBeat
Despite Recent Gains, Rezolute Insiders Are Still Down US$77k - simplywall.st
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) PT at $24.38 - Defense World
Charles Schwab Investment Management Inc. Purchases 9,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute director Hogenhuis purchases $19,733 in common shares By Investing.com - Investing.com South Africa
Rezolute Director Makes Bold Stock Purchase - TipRanks
Rezolute director Hogenhuis purchases $19,733 in common shares - Investing.com
rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com Australia
rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Canada
Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks
Rezolute Appoints Erik Harris to Board of Directors - TipRanks
Rezolute CFO Daron Evans acquires $57,700 in common shares By Investing.com - Investing.com South Africa
Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India
Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register
Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa
Rezolute expands board with biopharma veteran Erik Harris - Investing.com
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times
Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements - Yahoo Finance
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Kim Young-Jin | Director |
Jun 25 '24 |
Buy |
4.00 |
1,250,000 |
5,000,000 |
7,192,617 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
| Evans Daron | CFO |
Dec 09 '25 |
Buy |
5.04 |
10,549 |
53,167 |
131,900 |
| Hogenhuis Wladimir | Director |
Sep 24 '24 |
Buy |
4.70 |
4,259 |
20,017 |
41,767 |
| Hogenhuis Wladimir | Director |
Jun 25 '24 |
Buy |
4.15 |
4,815 |
19,982 |
37,508 |
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):